NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-028-2015-1-US-13 ANTI-MUTATED KRAS T CELL RECEPTORS US National Stage 15/528,813 11207394 Issued PDF
NCATS E-276-2011-0-JP-09 Compounds And Methods For The Prevention And Treatment Of Tumor Metastasis And Tumorigenesis JP DIV 2017-102107 Issued
NIDCR E-018-2003-0-US-13 POSTNATAL STEM CELLS AND USES THEREOF US CON 15/600,453 Abandoned
NCI E-065-2017-0-US-01 HUMAN MONOCLONAL ANTIBODY TARGETING TNFR2 FOR CANCER IMMUNOTHERAPY US 62/508,827 Abandoned
NCI E-028-2015-1-NZ-10 Anti-Mutated Kras T Cell Receptors NZ National Stage 732045 Issued
NCATS E-299-2012-0-US-06 BMP Inhibitors and Methods of Use Thereof US CON 15/598,540 10017516 Issued PDF
NCI E-106-2017-0-US-01 ANTI-MESOTHELIN POLYPEPTIDES AND PROTEINS US 62/508,197 Abandoned
NCI E-249-2017-0-US-01 METHODS TO INDUCE AN IMMUNE RESPONSE USING THERAPY WITH IMMUNOTOXINS AND ONCOL YTIC VIRUSES US 62/507,877 Abandoned
NCI E-019-2017-1-US-01 SHARPIN PEPTIDES AND THEIR USES US 62/508,158 Abandoned
NCI E-217-2011-1-US-11 Novel Interferon-Lambda4 (IFNL4) Protein, Related Nucleic Acid Molecules, and Uses Thereof US DIV 15/597,459 10962539 Issued PDF
NCI E-015-2018-1-PCT-02 Periodontitis Treatment PCT PCT PCT/BR2017/000051 Expired
NICHD E-057-2008-0-US-56 Use Of The Selective Progesterone Receptor Modulator CDB-2914 For Treating Uterine Leiomyomata And Stopping Bleeding In Patients Afflicted With Uterine Leiomyomata US CON 15/596,746 Abandoned
CC E-158-2017-0-US-01 SYSTEMS, METHODS, AND DEVICES FOR ASSISTING OR PERFORMING GUIDED INTERVENTIONAL PROCEDURES USING INERIAL MEASUREMENT UNITS AND MAGNETOMETER SENSORS US 62/506,872 Abandoned
NCI E-017-2017-0-US-01 CHIMERIC ANTIGEN RECEPTORS AND THEIR USES US 62/506,268 Abandoned
NIAID E-045-2015-0-US-04 NEUTRALIZING ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN AND THEIR USE US National Stage 15/526,661 10160795 Issued PDF
NIDDK E-034-2015-0-US-06 DEVICES, SYSTEMS AND METHODS FOR MANIPULATING SMALL MODEL ORGANISMS US National Stage 15/526,672 Abandoned
NCI E-056-2011-0-RU-42 YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS RU DIV 2017116350 Issued
NHLBI E-036-2015-1-US-02 NK CELLS WITH AN INCREASED ANTIBODY-DEPENDENT CELLULAR TOXICITY (ADCC) AGAINST TUMORS US National Stage 15/525,921 10813952 Issued PDF
NICHD E-039-2016-1-US-02 TREATMENT OF HORMONAL DISORDERS OF GROWTH US ORD 15/525,928 10350273 Issued PDF
NIAID E-357-2001-1-AU-30 WEST NILE VIRUS AND DENGUE 4 VIRUS CHIMERAS FOR USE IN A LIVE VIRUS VACCINE TO PREVENT DISEASE CAUSED BY WEST NILE VIRUS AU DIV 2017203108 Expired
NCI E-242-2015-1-KR-06 Peptide-Based Methods For Treating Pancreatic Cancer KR National Stage 10-2017-7012656 Pending
NCI E-019-2012-0-US-05 SOLUBLE ENGINEERED MONOMERIC FC US DIV 15/590,981 10633447 Issued PDF
CC E-149-2014-0-US-04 TOPICAL SODIUM NITRITE FORMULATION US National Stage 15/525,557 10272039 Issued PDF
NCI E-113-2016-0-PCT-02 VARIABLE NEW ANTIGEN RECEPTOR (VNAR) ANTIBODIES AND ANTIBODY CONJUGATES TARGETING TUMOR AND VIRAL ANTIGENS PCT PCT PCT/US17/031758 Abandoned
NIBIB E-150-2016-0-PCT-02 Chemical Conjugates of Evans Blue Derivatives and Their Use as Radiotherapy and Imaging Agents PCT PCT PCT/US17/031696 Expired
NCI E-127-2017-0-US-01 COMBINATION PDL1 AND TGF-BETA BLOCKADE IN PATIENTS WITH HPV+ MALIGNANCIES US 62/503,405 Abandoned
NCI E-093-2013-2-US-10 COMPOUNDS FOR INHIBITING DRUG-RESISTANT STRAINS OF HIV-1 INTEGRASE US DIV 15/589,590 10208035 Issued PDF
NHLBI E-201-2016-0-PCT-02 Annuloplasty Procedures, Related Devices And Methods PCT PCT PCT/US2017/031543 Expired
NCI E-226-2014-0-US-07 HUMAN ANTI-THYROGLOBULIN T CELL RECEPTORS US National Stage 15/524,869 10450372 Issued PDF
NIBIB E-099-2015-0-US-02 Labeled Evans Blue Dye Derivative For In Vivo Serum Albumin Labeling US DIV 15/587,948 10258701 Issued PDF
NIEHS E-179-2016-2-PCT-01 Methods for Improving Drug Delivery Across the Blood-Brain Barrier PCT PCT COMB PCT/US2017/031206 Expired
NCI E-069-2017-0-US-01 METHODS OF PREPARING A RE-USABLE SINGLE CELL AND METHODS FOR ANALYZING THE EPIGENOME, TRANSCRIPTOME, AND GENOME OF A SINGLE CELL US 62/502,247 Abandoned
NCI E-271-2014-0-US-02 A New Class Of Stable Heptamethine Cyanine Fluorophores And Biomedical Applications Thereof US National Stage 15/524,567 1028-03-07 Issued PDF
NIBIB E-149-2016-0-PCT-02 Albumin-binding Immunodulatory Compositions And Methods Of Use Thereof PCT PCT PCT/US2017/031098 Expired
NHLBI E-156-2016-0-PCT-02 ADENO-ASSOCIATED VIRUS POLYNUCLEOTIDES, POLYPEPTIDES AND VIRIONS PCT PCT PCT/US2017/030808 Expired
NIAID E-061-2016-0-PCT-02 NEUTRALIZING ANTIBODIES TO INFLUENZA HA AND THEIR USE AND IDENTIFICATION PCT PCT PCT/US17/030641 Expired
NCI E-144-2017-0-US-01 Haptens, Antibodies to Glycosylated Amino Acids, and Methods of Use US 62/500,275 Abandoned
NCI E-261-2016-0-US-04 Compositions And Methods Of Diazeniumdiolate-based Prodrugs For Treating Cancer US National Stage 15/523,670 10213445 Abandoned PDF
NCI E-123-2017-0-PCT-01 Antitumor Effect Of Cryptotanshinone PCT PCT PCT/US2017/030424 Expired
NHGRI E-044-2013-1-AU-03 OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA AU National Stage 2017258642 Issued
NHGRI E-044-2013-1-IN-10 OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA IN National Stage 201847043433 Issued
NHGRI E-044-2013-1-EA-08 OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA EA National Stage 201892467 Issued
NHGRI E-044-2013-1-CO-07 OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA CO National Stage NC2018/0012873 Issued
NHGRI E-044-2013-1-JP-11 OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA JP National Stage 2019-508165 Issued
NHGRI E-044-2013-1-KR-12 OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA KR National Stage 10-2018-7034615 Issued
NICHD E-039-2016-1-AU-03 Treatment of Hormonal Disorders of Growth AU National Stage 2015346277 Issued
NIDA E-073-2013-0-AU-07 Potent and Selective Inhibitors Of Monoamine Transporters; Method of Making; and Use Thereof AU DIV 2017202849 Issued
NIAID E-043-2010-0-US-06 Infectious Hepatitis C Viruses of Genotype 3A and 4A and Uses Thereof US CON 15/581,603 10100346 Issued PDF
NHGRI E-044-2013-1-PCT-02 OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA PCT PCT PCT/US2017/030174 Expired
NHGRI E-044-2013-1-CN-06 OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA CN National Stage 201780040785.7 Pending